Delayed hypersensitivity reaction related to the use of pegfilgrastim

Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis

(2012) Tallal Younis et al.   SUPPORTIVE CARE IN CANCER

Cutaneous reaction to pegfilgrastim presenting as severe generalized skin eruption

(2009) W.R. Scott et al.   BRITISH JOURNAL OF DERMATOLOGY

Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer

(2009) Ivan Bustillo et al.   Cutaneous and Ocular Toxicology

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

(2009) Stephen Jones et al.   JOURNAL OF CLINICAL ONCOLOGY

A Case of Prolonged Type 1 Hypersensitivity Reaction to Pegfilgrastim

(2008) G.G. Hanna et al.   CLINICAL ONCOLOGY

Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer

(2008) Ali Osman Kaya et al.   Cutaneous and Ocular Toxicology

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

(2008)   LANCET

Cutaneous reaction associated with weekly docetaxel administration

(2008) Lita Chew et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE